Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 40,000 shares at $57.78 ($2.3M) on 2023-10-18, disclosed to the SEC on 2023-10-19.
Scheduled sale ($2.3M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.53 | 8,758 | $513K | 22.1% |
| 2 | $58.53 | 8,758 | $513K | 22.1% |
| 3 | $57.78 | 6,242 | $361K | 15.6% |
| 4 | $57.78 | 6,242 | $361K | 15.6% |
| 5 | $57.06 | 10,000 | $571K | 24.6% |
| Total | $57.93 avg | 40,000 |
| $2.3M |
| 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |